Connection

Bruce Hollis to Prostatic Neoplasms

Back to Details
This is a "connection" page, showing publications Bruce Hollis has written about Prostatic Neoplasms.
Bruce Hollis
Connection Strength
0.843
Prostatic Neoplasms
  1. Vitamin D3 supplementation, low-risk prostate cancer, and health disparities. J Steroid Biochem Mol Biol. 2013 Jul; 136:233-7.
    View in: PubMed
    Score: 0.265
  2. Systems analysis of the prostate transcriptome in African-American men compared with European-American men. Pharmacogenomics. 2016 07; 17(10):1129-1143.
    View in: PubMed
    Score: 0.085
  3. Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab. 2012 Jul; 97(7):2315-24.
    View in: PubMed
    Score: 0.063
  4. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012 May 02; 104(9):690-9.
    View in: PubMed
    Score: 0.063
  5. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One. 2011 Apr 06; 6(4):e18625.
    View in: PubMed
    Score: 0.059
  6. Vitamin D deficiency and insufficiency among patients with prostate cancer. BJU Int. 2009 Oct; 104(7):909-14.
    View in: PubMed
    Score: 0.051
  7. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res. 2009 Feb 15; 69(4):1439-47.
    View in: PubMed
    Score: 0.051
  8. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst. 2008 Jun 04; 100(11):796-804.
    View in: PubMed
    Score: 0.048
  9. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. Prostate. 2007 Jun 15; 67(9):911-23.
    View in: PubMed
    Score: 0.045
  10. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol. 2004 May; 89-90(1-5):533-7.
    View in: PubMed
    Score: 0.036
  11. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control. 2004 Apr; 15(3):255-65.
    View in: PubMed
    Score: 0.036
  12. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1996 Feb; 5(2):121-6.
    View in: PubMed
    Score: 0.021
  13. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States) Cancer Causes Control. 1995 May; 6(3):235-9.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.